231 related articles for article (PubMed ID: 19269659)
1. A comprehensive analysis of recruitment and transactivation potential of K-Rta and K-bZIP during reactivation of Kaposi's sarcoma-associated herpesvirus.
Ellison TJ; Izumiya Y; Izumiya C; Luciw PA; Kung HJ
Virology; 2009 Apr; 387(1):76-88. PubMed ID: 19269659
[TBL] [Abstract][Full Text] [Related]
2. Kaposi's sarcoma-associated herpesvirus K-bZIP is a coregulator of K-Rta: physical association and promoter-dependent transcriptional repression.
Izumiya Y; Lin SF; Ellison T; Chen LY; Izumiya C; Luciw P; Kung HJ
J Virol; 2003 Jan; 77(2):1441-51. PubMed ID: 12502859
[TBL] [Abstract][Full Text] [Related]
3. Direct interactions of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50/Rta protein with the cellular protein octamer-1 and DNA are critical for specifying transactivation of a delayed-early promoter and stimulating viral reactivation.
Carroll KD; Khadim F; Spadavecchia S; Palmeri D; Lukac DM
J Virol; 2007 Aug; 81(16):8451-67. PubMed ID: 17537858
[TBL] [Abstract][Full Text] [Related]
4. K-bZIP of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 (KSHV/HHV-8) binds KSHV/HHV-8 Rta and represses Rta-mediated transactivation.
Liao W; Tang Y; Lin SF; Kung HJ; Giam CZ
J Virol; 2003 Mar; 77(6):3809-15. PubMed ID: 12610155
[TBL] [Abstract][Full Text] [Related]
5. Modulation of global SUMOylation by Kaposi's sarcoma-associated herpesvirus and its effects on viral gene expression.
Wang J; Guo Y; Wang X; Zhao R; Wang Y
J Med Virol; 2017 Nov; 89(11):2011-2019. PubMed ID: 28639696
[TBL] [Abstract][Full Text] [Related]
6. CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters.
Wang SE; Wu FY; Yu Y; Hayward GS
J Virol; 2003 Sep; 77(17):9590-612. PubMed ID: 12915572
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of the kaposi's sarcoma-associated herpesvirus transactivator K-Rta can complement a K-bZIP deletion BACmid and yields an enhanced growth phenotype.
Kato-Noah T; Xu Y; Rossetto CC; Colletti K; Papousková I; Pari GS
J Virol; 2007 Dec; 81(24):13519-32. PubMed ID: 17913803
[TBL] [Abstract][Full Text] [Related]
8. NF-kappaB serves as a cellular sensor of Kaposi's sarcoma-associated herpesvirus latency and negatively regulates K-Rta by antagonizing the RBP-Jkappa coactivator.
Izumiya Y; Izumiya C; Hsia D; Ellison TJ; Luciw PA; Kung HJ
J Virol; 2009 May; 83(9):4435-46. PubMed ID: 19244329
[TBL] [Abstract][Full Text] [Related]
9. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.
Wakeman BS; Izumiya Y; Speck SH
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795414
[TBL] [Abstract][Full Text] [Related]
10. Sirtuin 6 Attenuates Kaposi's Sarcoma-Associated Herpesvirus Reactivation by Suppressing Ori-Lyt Activity and Expression of RTA.
Hu M; Armstrong N; Seto E; Li W; Zhu F; Wang PC; Tang Q
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651359
[TBL] [Abstract][Full Text] [Related]
11. Role of CCAAT/enhancer-binding protein alpha (C/EBPalpha) in activation of the Kaposi's sarcoma-associated herpesvirus (KSHV) lytic-cycle replication-associated protein (RAP) promoter in cooperation with the KSHV replication and transcription activator (RTA) and RAP.
Wang SE; Wu FY; Fujimuro M; Zong J; Hayward SD; Hayward GS
J Virol; 2003 Jan; 77(1):600-23. PubMed ID: 12477864
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional repression of K-Rta by Kaposi's sarcoma-associated herpesvirus K-bZIP is not required for oriLyt-dependent DNA replication.
Rossetto C; Gao Y; Yamboliev I; Papousková I; Pari G
Virology; 2007 Dec; 369(2):340-50. PubMed ID: 17889220
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of regulation of RTA-responsive genes in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8.
Song MJ; Deng H; Sun R
J Virol; 2003 Sep; 77(17):9451-62. PubMed ID: 12915560
[TBL] [Abstract][Full Text] [Related]
14. Promoter- and cell-specific transcriptional transactivation by the Kaposi's sarcoma-associated herpesvirus ORF57/Mta protein.
Palmeri D; Spadavecchia S; Carroll KD; Lukac DM
J Virol; 2007 Dec; 81(24):13299-314. PubMed ID: 17913801
[TBL] [Abstract][Full Text] [Related]
15. Kaposi's sarcoma-associated herpesvirus K-Rta exhibits SUMO-targeting ubiquitin ligase (STUbL) like activity and is essential for viral reactivation.
Izumiya Y; Kobayashi K; Kim KY; Pochampalli M; Izumiya C; Shevchenko B; Wang DH; Huerta SB; Martinez A; Campbell M; Kung HJ
PLoS Pathog; 2013; 9(8):e1003506. PubMed ID: 23990779
[TBL] [Abstract][Full Text] [Related]
16. Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway.
Wang SE; Wu FY; Chen H; Shamay M; Zheng Q; Hayward GS
J Virol; 2004 Apr; 78(8):4248-67. PubMed ID: 15047839
[TBL] [Abstract][Full Text] [Related]
17. KSHV lytic proteins K-RTA and K8 bind to cellular and viral chromatin to modulate gene expression.
Kaul R; Purushothaman P; Uppal T; Verma SC
PLoS One; 2019; 14(4):e0215394. PubMed ID: 30998737
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of a new Kaposi's sarcoma-associated herpesvirus replication and transcription activator (RTA)-responsive element involved in RTA-mediated transactivation.
Wen HJ; Minhas V; Wood C
J Gen Virol; 2009 Apr; 90(Pt 4):944-953. PubMed ID: 19223488
[TBL] [Abstract][Full Text] [Related]
19. Kaposi's sarcoma-associated herpesvirus K-bZIP protein is necessary for lytic viral gene expression, DNA replication, and virion production in primary effusion lymphoma cell lines.
Lefort S; Flamand L
J Virol; 2009 Jun; 83(11):5869-80. PubMed ID: 19321621
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide identification of binding sites for Kaposi's sarcoma-associated herpesvirus lytic switch protein, RTA.
Chen J; Ye F; Xie J; Kuhne K; Gao SJ
Virology; 2009 Apr; 386(2):290-302. PubMed ID: 19233445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
